Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Scrt1, a transcriptional regulator of β-cell proliferation identified by differential chromatin accessibility during islet maturation


Glucose-induced insulin secretion, a hallmark of mature β-cells, is achieved after birth and is preceded by a phase of intense proliferation. These events occurring in the neonatal period are decisive for establishing an appropriate functional β-cell mass that provides the required insulin throughout life. However, key regulators of gene expression involved in functional maturation of β-cells remain to be elucidated. Here, we addressed this issue by mapping open chromatin regions in newborn versus adult rat islets using the ATAC-seq assay. We obtained a genome-wide picture of chromatin accessible sites (~ 100,000) among which 20% were differentially accessible during maturation. An enrichment analysis of transcription factor binding sites identified a group of transcription factors that could explain these changes. Among them, Scrt1 was found to act as a transcriptional repressor and to control β-cell proliferation. Interestingly, Scrt1 expression was controlled by the transcriptional repressor RE-1 silencing transcription factor (REST) and was increased in an in vitro reprogramming system of pancreatic exocrine cells to β-like cells. Overall, this study led to the identification of several known and unforeseen key transcriptional events occurring during β-cell maturation. These findings will help defining new strategies to induce the functional maturation of surrogate insulin-producing cells.


Pancreatic β-cells are highly specialized cells displaying the unique functional feature to release insulin in response to glucose and other stimuli. Inability of β-cells to secrete the appropriate amount of insulin to cover the organism’s needs leads to diabetes mellitus. β-cells acquire the ability to secrete insulin through a poorly understood postnatal maturation process involving transcriptional reprogramming of gene and non-coding RNA expression that becomes complete only after weaning1,2. In rats, this process occurs at around 21 days after birth1,3,4. Cells that produce and secrete insulin can be generated in vitro using various methods5,6 and are similar to β-cells in many aspects. However, these cells show lower glucose-stimulated insulin secretion (GSIS) and transcriptome differences compared with normal β-cells7. Consequently, there is a need to understand better the regulation of the maturation process to enable the engineering of fully functional surrogate insulin-producing cells. Likewise, the transcriptional control of pancreas development and islet differentiation remains a subject of intensive investigations8,9,10,11. In the past decade, the emergence of various next-generation sequencing technologies and experimental procedures have allowed querying of epigenome and gene expression profiles with unprecedented precision at a genome-wide or transcriptome-wide scale. Indeed, Ackermann et al. identified human α and β-cell specific mRNAs and regulatory elements using RNA-seq and ATAC-seq, respectively12. The ATAC-seq method probes DNA accessibility with a hyperactive Tn5 transposase, which inserts sequencing adapters into accessible chromatin regions. Sequencing reads can then be used to infer regions of increased accessibility, as well as to map regions of transcription factor binding and nucleosome position13. This allows the identification of transcription factors (TFs) that will bind to specific binding sites (TFBS) located in an open chromatin region, which can be close or distant to the transcription start site (proximal/distal regulation). Moreover, sets of TFs can cooperate on cis-regulatory modules (CRM), which are DNA stretches of about 100–1000 bp, to produce specific regulatory events14.

Taking advantage of this approach, we aimed at determining how neonatal islet maturation in rat is controlled at the transcriptional level, and to identify the key transcription factors involved. Open chromatin regions in the islets of 10-day-old (P10) and 3-month-old (adult) rats were analysed by ATAC-seq. About 100,000 putative regulatory regions were identified using this method, 20% of which displayed significant accessibility changes upon maturation. Using two different computational approaches to investigate potential TFBS motifs in the regions with accessibility changes, we identified putative regulatory elements in the promoter or in distal CRM of genes encoding differentially expressed mRNAs that may be implicated in islet maturation. As a result, a global picture of the transcriptional events taking place during pancreatic islet maturation was obtained. The involvement in post-natal β-cell maturation of a novel transcriptional regulator, Scrt1, identified in our computational analysis was confirmed experimentally. Scrt1 expression was found to be controlled by the transcriptional repressor RE-1 silencing transcription factor (REST) and to increase during the course of reprogramming of pancreatic exocrine cells into β-like cells15.


To study the transcriptional regulation of pancreatic islet maturation, we performed high throughput sequencing of transposase-accessible chromatin of newborn and adult rat islets (Fig. 1a). Post-natal β-cell maturation in rat has been shown to occur on a slightly different time frame compared to mice3,4,16. Consistent with the data in the literature we previously observed that P10 rat β-cells have a high proliferative capacity compared to adult mature β-cells but are unable to secrete insulin in response to glucose1. Therefore, we elected to compare chromatin accessibility in 10 days-old rat islets (P10) and in adult rat islets. Bioinformatic methods for reads alignment, quality control, peak detection, differential accessibility analysis and motif finding were applied. For example, the Magnesium Transporter 2 (Mrs2) locus depicts two prominent ATAC-seq signal peaks, and the 3′ end peak shows an important increase of accessibility after the maturation process (Fig. 1b). Quality control of the samples (Table 1) showed an average of 370 million reads sequenced with 94.3% of reads with a MAPQ score above 30. The analysis of fragment size distribution showed the expected profile of ATAC-seq (Supplementary Fig. S1a) with usual oscillations due to the presence of nucleosomes. In addition, adult and P10 samples were well clustered, when evaluated by the correlation between samples (Supplementary Fig. S1b) or using the first PCA component (Supplementary Fig. S1c). To detect accessible sites (ACS), we performed a peak calling using MACS217 (Methods), leading to the detection of ~ 102,000 ACS (Supporting Information 1). These sites were quantified in each sample separately and annotated with the closest transcription start site (TSS). Moreover, a differential accessibility analysis was performed using EdgeR18 (Fig. 1c, top), and the values of the analysis reported in the source data (1). ACS were divided in three groups: Stable, significantly more accessible in P10 (Down) and significantly more accessible in adults (Up), with p-value < 0.05 and FDR < 0.2. About 20% of the ACS showed differential accessibility upon maturation with 11.8% of down ACS and 7.1% of up ACS (Fig. 1c, bottom).

Figure 1

ATAC-seq successfully identified accessible sites (ACS) and transcription factor binding sites (TFBS) motif associated with pancreatic islet maturation. (a) Summary of the experimental design. Nuclei were extracted from the islets of 3 adult rats and 3 litters of rat pups at postnatal day 10 (P10) to perform the Tn5 reaction as described in51 and prepare the library for sequencing. The computational pipeline involved a quality control of the sequencing data followed by read alignment to the rat reference genome (Rn5 assembly). ACS were identified using the peak calling tool MACS217 and quantified for each sample separately. The ACS sequences were scanned using FIMO20 and analyzed to identify TFBS motifs that are implicated in the islet maturation process and in related pathways (See methods). (b) Example of identified ACS. The ACS nearby Mrs2 transcription end site is significantly higher in adult rats. This ACS contains several TFBS motifs. (c) Differential analysis of Trn5 integrations in accessible sites. On the top, the volcano plot representation of the log2 fold-change of Trn5 integration between P10 and adult rat islets in the x-axis, and the FDR adjusted p-value in the y-axis. ACS more accessible in adults are represented in green (Up), those more accessible in P10 in red (Down), and those remaining stable in blue (p-value < 0.05, FDR < 0.2, n = 3). Below, the barplot of the number of ACS changing along postnatal maturation and the donut plot of the percentage of Up, Down and stable ACS. (d) Motif enrichment analysis in ACS identified putative regulators of postnatal pancreatic islet maturation. The left panels represent four enriched TFBS motifs. The right panel represents the FGSEA normalized enrichment score for top enriched motifs (FGSEA adjusted p-value < 0.05). See also Supplementary Figure S1 and Supplementary Table 1,2,3.

Table 1 ATAC-seq libraries quality control.

Promoter and distal ACS depicted distinct accessibility patterns along islet maturation

To assess the impact of the ACS location in respect to the closest gene, we used ChIPseeker19 to annotate our ACS and 100,000 randomly selected sites (Supplementary Fig. S1d). ACS were enriched for exonic and intronic sequences and transcript start sites as opposed to random sites (Supplementary Fig. S1e). Interestingly, ACS more accessible in adults (up), were enriched in distal sites and intron as compared to ACS less accessible in adults (down), which were enriched in promoters. We observed that 2/3 of the ACSs were distal sites and about 10% were located in the TSS or proximal class.

Identification of transcriptional regulators and chromatin remodelers of pancreatic islet maturation

Accessibility analysis enables the detection of TFs or TFBS affecting the chromatin state and the transcription of nearby genes. In order to decipher the combinatorial code of transcription factor binding sites that allows islet maturation, we scanned the sequence of each ACS using FIMO20 together with the position weight matrices of Jaspar 201621. With these sequence scans we could perform a motif set enrichment analysis for the accessibility in P10 or in adult islet cells using the FGSEA algorithm22 (Supplementary Table 2, Fig. 1d). Thus, using the set of significantly changing ACS and their respective accessibility log2 Fold Change, we were able to identify TFBS motifs that were either enriched in P10 or in adult rat islets. Several TFBS, previously implicated in islet maturation, were significantly enriched, such as MAF, FOX, FOS/JUN, NRF, and E2F23,24,25,26,27,28. Moreover, several motifs recognized by transcriptional repressors and insulators such as SCRT1 or CTCF were also enriched in P10 islets. To confirm these results and detect additional motifs playing a role in islet maturation, we applied a penalized linear model GLMnet29 to all ACS with the matrix of motif match as predictors and the log2 fold-change as output vector. With this method, an activity (β) for each motif was computed (Supplementary Table 3). This allowed to confirm most of the hits discovered using the FGSEA and to detect additional TFBS motifs such as RFX, SREB, NKX6, REL, MEIS, and TEAD3.

Table 2 qPCR primer sequences (rat).
Table 3 qPCR Primer Sequences (mouse).

ACS significantly affected were located near genes involved in islet maturation

Next, we investigated if ACS changing in P10 versus adult rat islets control the expression of genes displaying significant differences upon maturation30. Of the 19,311 ACS differentially accessible, 11,372 (~ 60%) were located in the vicinity of differentially expressed genes. These ACS were annotated as enhancers or repressors, depending whether their accessibility was respectively correlated or anti-correlated with the expression changes in the nearby gene (Supporting Information 1). As previously described30, several KEGG pathways were enriched by analyzing significantly changing genes nearby differentially accessible ACS. For instance, insulin secretion, circadian rhythm, and calcium signalling were enriched in adult, while carbon metabolism, PI3-Akt, and proliferation related annotations (cancer) were enriched in P10 (Supporting Information 1). Enhancer and repressor ACS contribute to the output gene expression. Thus, a gene may be regulated by several ACS, some bound by enhancer proteins, and others targeted by repressors.

ACS display enhancer activity

Next, we experimentally tested if the identified ACS located near genes important for proper pancreatic β-cell function31 display enhancer activity. For this purpose, 5 ACS sequences (Supplementary Table 4, Fig. 2a–c) near Syt4, Pax6 (two ACS), Mafb and NeuroD1 were cloned in a luciferase reporter construct driven by a minimal promoter. Interestingly, the inclusion of the ACS close to Syt4, MafB, and NeuroD1 resulted in an increase in luciferase activity, compared to the empty pGL3 vector. In addition, mRNA expression of NeuroD1 and MafB, tested by qPCR (Fig. 2d), confirmed the higher expression of these genes in 10-day-old pups. MAFB was previously described as a regulator of the pancreatic β-cell function32 and its expression to be decreased during β-cell maturation in mice23 (reported in Supplementary Fig. S2b). Here we detected a cis-regulatory elements containing various TFBS motifs including Meis1,2 or Glis2 located more than 10Kbp away from the Mafb gene that was less accessible in adult rats (Supplementary Fig. S2a). Thus, we concluded that the identified ACS are likely to be involved in transcriptional regulation of nearby genes.

Figure 2

Source data (4) and supplementary Fig. S3.

Enhancer activity assessment and Scrt1 function. (a) Trn5 integrations on Mafb, Syt4, Neurod1 and two Pax6 accessible sites. (b) Scheme of pGL3 vector used for the luciferase assay. (c) Luciferase activity was measured in INS 832/13 cells transfected with an empty pGL3 vector (Ctrl) or a pGL3 vector containing an enhancer region for the indicated gene (Mafb, NeuroD1, Pax6 and Syt4). Results are expressed as fold change versus control. (d) Gene expression in P10 and adult rat islets were measured by qPCR and normalized to the housekeeping gene Hprt1. Syt4 gene expression is available in Fig. 3. * p < 0.05, ** p < 0.01 by Student’s t-test or by one-way Anova, Dunnett’s post-hoc test. (ef) Scrt1 expression was measured by qPCR and normalized to Hprt1 housekeeping gene levels. (fj) Dispersed adult rat islet cells were transfected with a control siRNA (siCtl) or siRNAs directed against Scrt1 (siScrt1). Experiments were performed 48 h post-transfection. Insulin release in response to 2 or 20 mM glucose (g,h) insulin content were determined by ELISA n = 3. (i) Apoptosis of insulin-positive cells was assessed using Tunel assay in basal (NT) condition or in response to a mix (cyt mix) of pro-inflammatory cytokines (IL-1β, TNF-α and IFN-γ) n = 5. (j) The fraction of proliferative insulin-positive cells was determined by BrdU incorporation in basal (NT) or stimulated (prolactin, PRL) conditions, n = 6. * p < 0.05, ** p < 0.01 by Student’s t-test or by one-way Anova, Tukey’s post-hoc test. See also

Scrt1 represses β-cell proliferation

We next focused on Scrt1, a transcriptional repressor involved in neuroendocrine development33,34,35 but whose functions in β-cells remain to be determined. Binding sites for this transcriptional repressor were highly enriched in the chromatin regions that close upon β-cell maturation. Thus, our hypothesis was that Scrt1 binding in those sites would close the chromatin. In agreement with the lower chromatin accessibility for Scrt1 binding sites, Scrt1 expression is increased in adult rat islets compared to immature islets (Fig. 2e, Supplementary Fig. S2d). Interestingly looking into the data-set published by Qiu et al. 23, Scrt1 expression was also found to be augmented during maturation of mouse β-cells (Supplementary Fig. S2c). Transfection of adult rat islet cells with a set of siRNAs targeting Scrt1 led to a decrease in the expression of the repressor of about 70%. (Fig. 2f). Scrt1 knockdown neither affected glucose-stimulated insulin secretion (Fig. 2g) nor insulin content (Fig. 2h). Apoptosis measured by Tunel assay in both control condition or in response to pro-inflammatory cytokines was also not affected (Fig. 2i, supplementary Fig. S3a). Interestingly, knockdown of Scrt1 in adult β-cells resulted in a rise in proliferation, suggesting an involvement of this transcriptional repressor in postnatal β-cell mass expansion (Fig. 2j, supplementary Fig. S3b).

Identification of Scrt1 targets involved in maturation

As Scrt1 appears to regulate the proliferative capacity of β-cells, we next aimed at finding its targets. For this purpose, adult rat islet cells were FACS-sorted to separate α-cells and β-cells. We observed that α-cells and β-cells express Scrt1 at similar levels (Supplementary Fig. S4a). Subsequently, an RNA-seq on β-cells exposed to a control siRNA or to siScrt1 was performed. Differential expression analysis between siScrt1 and control samples revealed that 168 genes were significantly impacted by silencing Scrt1 with a FDR adjusted p-value below 0.05 (Fig. 3a). Of these 168 genes, 111 were down-regulated and 57 were up-regulated. The significantly changing genes were enriched with ACS containing Scrt1 motif in their surroundings (hypergeometric test p-value < 10–6). We then looked at the log2 Fold-change distribution of ACS located at the TSS, proximal or distal (Fig. 3b). We observed that genes having a Scrt1 motif containing ACS at the TSS or proximal were increased upon siScrt1 while a substantial part of the distal Scrt1 ACS were decreased. As expected, among the potential targets of Scrt1 we found genes related to proliferation such as Notch1, Parp16, Ppp3r1, Ppp2r1b and Ywhag (Fig. 3c). Moreover, some genes related to glucose signalling and GSIS such as Syt4, or to sphingolipid metabolism as Ugt8 were down-regulated when knocking down Scrt1. Then, we compared the set of genes affected by Scrt1 silencing and the ones differentially expressed upon maturation (in postnatal 10-day-old (P10) versus adult rat islets). A common set of 62 genes was found to change in both data sets with an FDR adjusted p-value below 0.05 (Fig. 3c, Supplementary Table 7). In addition, a gene ontology (GO term) enrichment analysis for biological processes revealed that autophagy and oxygen sensing are over represented in these 62 genes (Supplementary Table 8). Interestingly, a significant anti-correlation (Pearson’s correlation test, p-value = 0.013) was observed between the fold-changes from the comparison between siScrt1 versus siCtl in adult rat β-cells and P10 versus adult islets. The opposite change in the expression of Nfatc1, Nfatc2, Notch1 and Syt4 in response to Scrt1 downregulation versus islet maturation was also confirmed (Fig. 3f,g, Supplementary Fig. S5).

Figure 3

Changes induced by silencing Scrt1 were anti-correlated with the maturation signature of islet cells. FAC-sorted adult rat β-cells were transfected with a control siRNA (siCtl) or siRNAs directed against Scrt1 (siScrt1). RNA extraction and library preparation for RNA-seq were performed 48 h post-transfection. (a) Volcano plot of gene expression changes induced by Scrt1 knockdown. SCRT1 putative target genes (defined based on the presence of SCRT1 motif in ACS in the proximity of the gene) significantly altered are indicated with red dots and labels. In the top left, normalized counts from the RNA-seq data of Scrt1 expression is represented with a barplot. (b) log2 fold changes distribution of significantly altered genes by siScrt1 containing a SCRT1 motif in an ACS either at the TSS (± 1Kbp), proximal (1-10Kbp) or distal (more than 10Kbp) from the gene. (c) Scatter plot of log2 fold changes of differentially expressed genes from adult/P10 measured by micro-array (n = 3) versus log2 fold changes of siScrt1/control measured by RNA-seq (n = 5). Several genes of interest are represented with their label. (d) Enrichment plot for two significant annotations using the FGSEA algorithm. (e) Scheme describing the siScrt1 hypothesis. Briefly, the siRNA for Scrt1 will reduce the mRNA level of the Scrt1 gene and consequently the level of the protein. Thus, lower binding of SCRT1 will occur at target sites that will affect proliferation and specialization of β-cells. qPCR confirmation of gene expression in (f) FAC-sorted β-cells transfected with siCtrl or siScrt1 or in (g) P10 versus adult rat islets. Student T test, *p < 0.05, **p < 0.01. See also Supplementary Fig. S5 and Supplementary Tables 5, 6, 7, 8.

Next, we looked at the enriched gene ontologies using the FGSEA algorithm on the RNA-seq of siScrt1 and siCtrl. Cell proliferation and pattern specification process were among the highest hits (Supplementary Table 5, Fig. 3d).

Taken together our results suggest that Scrt1 act as a repressor that regulate proliferation through de-repression of genes at their TSS or in cis-regulatory elements, while specialization seems to occur through distinct mechanisms involving distal ACS (Fig. 3e).

Scrt1 is a target of REST and is induced in exocrine to β-cell reprogramming

To gain insights in to the mechanisms underlying Scrt1 regulation during β-cell maturation, we analysed previously published ChIP-seq data for hallmark β-cell transcription factors in mouse islets36,37,38. Interestingly, the Scrt1 locus is bound by PDX1, FoxA2, NeuroD1, INSM1 and NKX6-1 (Fig. 4a). Moreover, this locus is marked by H3K4Me3 in islets39, suggesting that the Scrt1 gene is active in the endocrine pancreas. Since REST (RE-1 silencing transcription factor) was previously reported to be an important repressor of β-cell genes that is silenced in adult islets15,40,41, we also reanalysed the binding of this transcriptional repressor42 to the Scrt1 locus. Interestingly, REST binds the Scrt1 locus in non-islet mouse and human cells (ES and Panc1 cells) (Fig. 4a, Supplementary Fig. S6), suggestive of a REST-mediated repression of the Scrt1 gene. Given the identification of a REST binding site upstream of Scrt1 gene (Fig. 4a), and a specific expression of Scrt1 in endocrine and not in exocrine cells (Fig. 4c), as well as the recently published involvement of REST in acinar to β-cell reprogramming84, we sought to test the regulatory role of REST on Scrt1 expression, in this biologically relevant and well controlled reprogramming system.

Figure 4

Scrt1 is negatively regulated by REST in β cells, exocrine cells and reprogrammed β-like cells. (a) The mouse Scrt1 locus showing hallmark β-cell transcription factor binding sites and H3K4Me3 in β-cells and REST binding in mES cells. (b) Scheme describing the experiments done in (ci). Normalized counts from RNA-seq data showing Scrt1 (c) and Rest (d) expression in cultured mouse primary exocrine cells and in isolated primary β-cells. Primary exocrine cells are the mCherry-/GFP- as described in (g,h). Primary β-cells are the GFP + FAC-sorted fraction of islets isolated from MIP-GFP mice. Results are mean normalized counts ± SD, and ***p < 0.001, n = 4. (e) Min6 cells were infected with Ad-mCherry control virus or Ad-hREST and 3 days post infection gene expression was measured by qPCR and normalized by housekeeping gene (Tbp). Results are presented as relative expression versus Ad-mCherry control and are mean ± SD; ** p < 0.001 on t-test, n = 4. (f) Primary exocrine cells were infected with Ad-mCherry control or Ad-DN-REST viruses and 5 days post-infection Scrt1 expression was analyzed by qPCR and normalized by Tbp. Results are presented as relative expression levels versus Ad-DN-REST group and are mean ± SD; n = 4. Normalized counts from RNA-seq data showing Scrt1 (g) and Rest (h) expression in reprogrammed β-like cells from primary exocrine cells. Primary exocrine cells isolated from MIP-GFP mice were infected with Ad-M3-mCherry virus. Day 3 and 6 Cherry/GFP fractions were FAC-sorted as indicated. Cherry + represents the M3-infected fraction and the GFP + fraction enriched for reprogrammed β-like cells. Results are mean normalized counts ± SD, *p < 0.05, n = 4. (i) FAC-sorted day 5 reprogrammed exocrine cells expressing M3-mCherry and LacZ or REST. mCherry fractions were FAC-sorted and Scrt1 expression was analyzed by qPCR and normalized by Tbp. Results are presented as relative expression levels versus mCherry + fraction of Ad-mCherry + Ad-LacZ control virus group, and are mean ± SD; *** p < 0.001, n = 4. See also Supplementary Fig. S6 and Supplementary Table 9.

To address the potential repression of Scrt1 by REST in pancreatic cells, a series of experiments were performed on mouse exocrine, β-, and reprogrammed β-like cells, as described in Fig. 4b. First, analysis of previously published transcriptomic data15, shows that Scrt1 (Fig. 4c) and Rest expression (Fig. 4d) is inversely correlated in exocrine cells and in β-cells. A high expression of Scrt1 in β-cells was observed, while Rest was expressed only in exocrine cells. Next REST was overexpressed in the mouse insulinoma cell line MIN6 and gene expression was analysed by qPCR for Rest, Ins2, Pdx1, Snap25 and Scrt1 three days post infection (Fig. 4e). While Ins2 and Pdx1 (not direct targets of REST) were unaffected by Rest overexpression, Snap25 (a known target of REST40) and Scrt1 expression were significantly reduced. Opposite results were obtained in primary exocrine cells infected with Ad-mCherry control or Ad-DN-REST virus (encoding a dominant negative REST protein43). At 5 days post-infection, Scrt1 expression was significantly higher when Rest was silenced using the dominant negative mutant (Fig. 4f). These results are consistent with a REST-mediated repression of the Scrt1 gene. Next, we examined Scrt1 and Rest expression levels in a model of β-like cells undergoing reprogramming from primary exocrine cells 3 and 6 days post-infection6,15. A continuous accumulation of Scrt1 mRNA and a parallel reduction in Rest were observed (Fig. 4g,h). Lastly, Rest overexpression in FACS-sorted reprogrammed cells resulted in a marked decrease in Scrt1 expression (Fig. 4i). Taken together, our results demonstrate that Scrt1 is controlled by REST. Thus, REST represses Scrt1 in exocrine cells and Scrt1 increases during reprogramming in parallel with a concomitant decline in Rest expression.


Postnatal islet maturation is a critical process to achieve proper β-cell function. Immediately after birth, β-cells are not fully functional and have to undergo a major gene reprogramming to acquire the ability to secrete adequate amounts of insulin in response to glucose44. Our group and others7,23,30,45 have shown a large-scale rewiring of transcriptional programs occurring during the neonatal period. However, little is known on cis-regulation of gene expression at the chromatin level before and after weaning. Chromatin accessibility of human islets on a genome-wide scale has been previously produced using FAIRE-seq31,46. More recently, several studies took advantage of ATAC-seq together with GWAS to identify causal variants of T2D in cis-regulatory elements in human47,48,49,50. Another study identified cell-type specific accessible sites and transcription factor binding sites in α, β and acinar cells12. However, the transcriptional regulation of postnatal islet maturation at the chromatin level has not been reported so far. In this project, we employed ATAC-seq13,51 to produce a global map of accessible sites (ACS) in the islets of 10-day-old pups and in adult rats. This permitted to detect more than 100,000 ACS, among which about 20% were differentially accessible before and after the functional maturation of β-cells. Interestingly, the ACS with the most significant p-value and a large fold-change was located on the 3′UTR of the Mrs2 gene. This gene is encoding a magnesium transporter at the surface of the mitochondria52. Genetic variants in this magnesium-related ion channel were previously associated with type 2 diabetes and pancreatic cancer53,54.

Using two different computational approaches and the Jaspar PWM database, we could find known and unforeseen transcriptional regulators potentially involved in the maturation process. We identified many DNA-binding proteins affecting chromatin accessibility, including MAF, FOX, FOS/JUN, NRF, E2F, CTCF, RFX, SREB, NKX6, REL, MEIS, TEAD and SCRT1. Several of these transcription factors have been already implicated in pancreas development and postnatal islet maturation55. For instance, E2F1 is an established cell survival and proliferation activator in β-cells28 and we have recently shown that this transcription factor controls the expression of the long non-coding RNA H19 and is profoundly down-regulated during the postnatal period. Moreover, we obtained evidence suggesting that E2F1 and H19 may contribute to the decrease in β-cell mass in the maternal low protein diet offspring model45.

Next, we integrated these accessibility maps with mRNA micro-array data from30,45 in the same model and we found that ~ 60% of the differentially accessible sites were nearby differentially expressed genes, suggesting that these cis-regulatory elements are involved in the transcriptional regulation of gene expression. Several pathways previously related to the maturation process such as insulin secretion or circadian rhythms are under the control of these accessible cis-regulatory elements. For instance, several components of the core clock are not rhythmic in 10 days old pups but are consistently oscillating in β-cells after weaning56. It has been recently demonstrated that circadian rhythms trigger islet maturation via clock-controlled metabolic cycles27. These cis-regulatory elements may be controlled by transcriptional enhancers or repressors. Indeed, we confirmed that 3 out of the 5 tested ACS that are located nearby genes important for proper β-cell function had a significant enhancer activity. These ACS were located nearby Syt4, Neurod1, and Mafb. We showed that an enhancer site and the promoter of Mafb depicted a decreased accessibility along maturation. Mafb is required at the early stage of β-cells maturation and decreases in later stages32. We observed that an enhancer near Neurod1 was significantly more accessible and Neurod1 expression was higher in mature β-cells. Another group showed that overexpression of Mafa results in increased Neurod1 expression57, and that Mafa is crucial to induce glucose-responsive insulin secretion in neonatal rat β-cells. We showed that Syt4 is a potential target of NFAT, FOX and RFX TFs family (Supplementary Fig. S5). Syt4 expression was correlated with its enhancer accessibility and was higher in fully mature β-cell. Syt4 is known to modulate Ca2+ sensitivity of insulin granules and consequently enhance GSIS58.

One of the identified transcriptional regulators, SCRT1, is of particular interest. Scrt1 was previously shown to be implicated in brain development33,34 but its role in β-cells remained to be determined. While this manuscript was under revision, Scrt1 was suggested to act as a regulator of insulin expression and secretion in response to glucose in combination with a cAMP raising agent (IBMX)59. Here, downregulation of Scrt1 in adult rat islets did not impact insulin release in response to only high concentration of glucose but induced β-cell proliferation, suggesting that reduced expression of Scrt1 in P10 islets may favour the acquisition of an appropriate β-cell mass during the neonatal period. Indeed, transcripts related to proliferation were significantly impacted by the downregulation of Scrt1 in FACS-sorted adult β-cells. Interestingly, a significant increase of Scrt1 in adult islet cells was also reported in a recent study analyzing age-dependent gene expression and chromatin changes in human60. RNA-seq analyses suggest that Scrt1 affects Syt4, Notch1 and Nfatc1 and Nfatc2 gene expression and consequently may control the calcineurin/NFAT pathway, an important regulator of β-cell growth and function61,62. Functional enrichment analysis showed that Scrt1 also influences the expression of genes related to oxygen sensing and autophagy. Accordingly, previous studies have demonstrated a role for the hypoxia-inducible factor HIF1a in normal β-cell function63, and altered β-cell autophagy in human T2DM64.

Intriguingly, Ackermann and others5,12 pointed out that many poised genes in α cells contain a signature of functional β-cells and, consequently, could be of use for α-to-β cell reprogramming. This suggests plasticity and specialization of the different cell types along maturation and rewiring of transcriptional programs at the chromatin level. In fact, reprogramming of acinar cells into insulin-producing cells has been accomplished using adenoviral gene delivery of PDX1, NGN3 and MafA6. A subsequent study characterized these changes using RNA-seq and ChIP-qPCR and revealed that loss of Rest combined with Pdx1 expression leads to activation of endocrine genes and correlates with epigenetic modifications of local chromatin15. In this study, we provide evidence indicating that Scrt1 is a direct target of REST in different mouse and human cell models. Moreover, overexpression of Rest inhibits Scrt1 expression in β-cells and in β-like cells reprogrammed from exocrine cells. Islet plasticity is of interest for the design of future treatments of diabetes through the production of mature surrogate insulin-producing cells65. Thus, understanding the role of Scrt1 in the reprogramming process will be important to improve the generation of mature surrogate insulin-producing cells. REST downregulation has been suggested to be involved in postnatal β-cell maturation in response to thyroid hormones57 and it is tempting to speculate that Scrt1 derepression might also contribute to this process.

In this study, ATAC-seq and the mRNA microarray analyses have been performed in whole islets and not in FACS-sorted cells or in single cells. Several recent studies have demonstrated a large heterogeneity of gene expression at a single cell level using smFISH or single cell RNA-seq23,66,67,68. Taking advantage of the heterogeneity of gene expression together with single cell ATAC-seq could shed more light on the transcriptional control of islet maturation and the different cell types involved.

Overall, we produced a high-resolution map of chromatin accessible sites in islets of 10-day-old pups and adult rats (Fig. 5a). These genome wide accessibility maps are an important resource to study cis-regulation of gene expression along islet cell maturation. Using these maps, we discovered a new important transcriptional repressor implicated in the maturation process, namely Scrt1, which controls β-cell proliferation and function. Scrt1 is controlled by REST and its expression is increased along acinar to β-cell reprogramming (Fig. 5b). Manipulations of the level or the activity of this transcriptional regulator may favour the development of new approaches aiming at generating surrogate insulin-secreting cells. A global understanding of the molecular mechanisms and of the transcription factors involved in functional maturation will be seminal for the design of β-cell-based replacement strategies for the treatment of diabetes.

Figure 5

Summary figure: Chromatin accessibility along maturation is affected by Scrt1. In the present study we investigated the chromatin accessibility along the post-natal pancreatic islet maturation process. (a) SCRT1 motif is enriched in ACS that are closing upon maturation. We found that Scrt1 is a direct target of REST and that the Scrt1 motif is present in TSS/proximal sites as well as distal sites. The inhibition of Scrt1 lead to increased proliferation and has additional effects on other processes such as specialization. (b) In an in vitro reprogramming system, Scrt1 expression raises after PNM infection and is anti-correlated with REST levels.

Methods and materials


Male (200-250 g, around P90) and pregnant Sprague–Dawley rats were obtained from Janvier laboratories (Le Genest St- Isle, France). After birth, male and female pups were nursed until sacrifice at P5, P10, P20 or P23. Animals were housed under standard temperature (20-24ºC) and humidity (40–70%) conditions on a 12 h light/dark cycle with free access to chow diet and water. All procedures were performed in accordance with the Guidelines for the care and use of laboratory animals from the National Institutes of Health and of ARRIVE and were approved by the Swiss Research Councils and Veterinary Office. All animal experiments involving reprogramming of exocrine cells isolated from C57BL/6JOlaHsd or MIP-GFP mice, were approved by the Weizmann Institute Institutional Animal Care and Use Committee.

Islet isolation, dispersion and sorting

Islets were isolated by collagenase digestion of the pancreas69. In more details, P5 and P10 pancreases of 3–5 pups were collected, pooled and digested by hand shaking in 3 ml of collagenase P solution (Sigma) at 1 mg/ml for 3–5 min, while 3 or 10 ml of collagenase P solution were injected in the pancreatic duct of P20–23 pup and adult rats, respectively, followed by 8 and 15 min digestion in a warm bath. After digestion, islets were separated from the exocrine tissue using an histopaque density gradient followed by hand-picking and were incubated for 2 h in RPMI 1640 GlutaMAX medium (Invitrogen) containing 11 mM glucose and 2 mM l-glutamine and supplemented with 10% fetal calf serum (Gibco), 10 mM Hepes pH 7.4, 1 mM sodium pyruvate, 100 μg/mL streptomycin and 100 IU/mL penicillin. Dissociated islet cells were obtained by incubating the islets in Ca2+/Mg2+ free phosphate buffered saline, 3 mM EGTA and 0.002% trypsin for 5 min at 37 °C. For some experiments, islet cells were separated by Fluorescence-Activated Cell Sorting (FACS) based on β-cell autofluorescence, as previously described70,71. Sorted islet cells were seeded on plastic dishes coated with extracellular matrix secreted by 804 G rat bladder cancer cells (804 G ECM)72. Enrichment of α- and β-cells was evaluated by double immunofluorescence staining using polyclonal guinea pig anti-insulin (dilution 1:40, PA1-26938 Invitrogen) and polyclonal mouse anti-glucagon (dilution 1:1000, Abcam Ab10988) antibodies, followed by goat anti-guinea pig Alexa-Fluor-488 and goat anti-mouse Alexa-Fluor-555 (diluted 1:400, Thermofisher A11073 and A21422, respectively) secondary antibodies. On average, β-cell fractions contained 99.1 ± 0.9% insulin-positive cells and 0.6 ± 0.6% glucagon-positive cells and α-cell-enriched fractions contained 10.6 ± 8.2% insulin-positive cells and 88.8 ± 8.2% glucagon-positive cells.

ATAC-seq sample preparation

ATAC-seq libraries were prepared as previously described51 using dissociated islet cells from 3 adult male rats and from a mix of few P10 pups of 3 different litters. Briefly, 100′000 islet cells were resuspended in 50 μl of cold lysis buffer (10 mM Tris–HCl pH7.4, 10 mM NaCl, 3 mM MgCl2 and 0.1% IGEPAL CA-630) and centrifuged at 500 g for 10 min at 4 °C. The pellet was resuspended in the transposase reaction mix (Nextera kit, Illumina). The transposition reaction was performed at 37 °C for 30 min and was followed by purification of the samples using the Qiagen MinElute PCR purification kit (Qiagen). Transposed DNA fragments were amplified for 11 cycles using the NEBnext high-fidelity PCR master mix and the Ad1_noMX and Ad2.1–2.6 barcoded primers from51. Amplified libraries were purified with AMPure XP beads (Beckman Coulter) to remove contaminating primer dimers. Library quality was assessed using the Fragment Analyzer and quantitated using Qubit. All libraries were sequenced on Illumina HiSeq 2500 using 100 bp paired-end reads.

ATAC-seq data quality control and analysis

Fastq files quality was assessed using FastQC (version 0.11.2)73. Raw reads were aligned to the Rattus norvegicus reference genome assembly 5 (Rn5) using BWA (version 0.7.13)74 with default settings. Quality control of the aligned reads was checked using Samstat (version 1.5)75 and processed with Samtools (version 1.3)76. Reads mapping to mitochondrial DNA were discarded from the analysis together with low quality reads (MAPQ < 30). Peak calling was performed in order to find accessible sites (ACSs) using Macs2 (version 2.1.1)17 on adult and P10 samples concatenated separately. ACSs were then reunited in a single bed file and quantified using the pyDNase library (version 0.2.5)77 (Table 1). We used FIMO20 from the MEME suite (version 4.11.4) together with Jaspar 2016 position-weight matrices21, to predict transcription factor binding sites. Finally, we used the R statistical software (version 3.4.2) and several bioconductor and CRAN packages to perform gene sets enrichment analysis (RDavidWebService, ClusterProfiler)78, ACSs localization analysis (ChIPseeker)19, motif enrichment analysis (FGSEA, Supplementary Table 2)22 and penalized linear model analysis (GLMnet, Supplementary Table 3)29 for motif selection. All sequencing tracks were viewed using the Integrated Genomic Viewer (IGV 2.4.8)79. ATAC-seq raw data were deposited in GEO under the accession number GSE122747.

mRNA microarray

P10 and adult mRNA expression from30,45 were reanalyzed with EdgeR and RDavidWebservice18,80 (supplementary Table 6). These microarray data are available in the GEO database under the accession number GSE106919.

Cell line

The INS 832/13 rat β-cell line was provided by Dr. C. Newgard (Duke University)81 and was cultured in RPMI 1640 GlutaMAX medium (Invitrogen) containing 11 mM glucose and 2 mM L-glutamine and supplemented with 10% fetal calf serum (Gibco), 10 mM Hepes pH 7.4, 1 mM sodium pyruvate and 0.05 mM of β-mercaptoethanol. INS 832/13 cells were cultured at 37 °C in a humidified atmosphere (5% CO2, 95% air) and tested negative for mycoplasma contamination. MIN6 cells were a kind gift from Prof. J. Miyazaki (Osaka University). Min6 cells were culture in DMEM medium containing 11 mM d‐glucose supplemented with 15% fetal calf serum, 200 IU/ml penicillin, 100 μg/ml streptomycin, 2 μM l‐glutamine, and 72 μM β-mercaptoethanol. For experiments involving infections with Ad-hREST adenovirus, 300,000 cells per well were plated on 24-well plates and were harvested 72 h post infections.

Cell transfection

Dispersed rat islet cells or FACS-sorted β-cells were transfected with a pool of 4 siRNAs directed against rat Scrt1 or a negative control (On-Target plus 081299-02 and 001810-10 respectively, Dharmacon) using Lipofectamine RNAiMAX (Thermofisher). INS 832/13 cells were co-transfected with pGL3 promoter and psicheck plasmids (Promega) using lipofectamine 2000 (Thermofisher). pGL3 promoter vector was empty (control) or contained an enhancer region for MafB, NeuroD1, Pax6 or Syt4 (RNA synthesis, subcloning and plasmid sequencing were performed by GenScript, Netherlands) (Supplementary Table 4). RNA extraction and functional assays were performed 48 h after transfection.

Luciferase assay

Luciferase activities were measured in INS 832/13 cells using the Dual-Luciferase Reporter Assay System (Promega). Firefly luciferase activity was normalized to Renilla luciferase to minimize experimental variabilities. Experiments were performed in triplicates.

RNA extraction, quantification and sequencing

RNA was extracted using miRNeasy micro kit (Qiagen) followed by DNase treatment (Promega). Gene expression levels were determined by qPCR using miScript II RT and SYBR Green PCR kits (Qiagen) and results were normalized to the housekeeping gene Hprt1. Data were analyzed using the 2−ΔΔC(T) method. Primer sequences are provided in Table 2. For mRNA-sequencing, the RNA was converted into a sequencing library using the Illumina TruSeq RNA-sequencing kit and standard Illumina protocols. Single-end, 151 nt long reads were obtained using a HiSeq 4000 instrument. Reads were aligned to the transcriptome (Rnor6) with Kallisto82 and presented as transcripts per million (TPM) and EST pseudo counts (Suppementary table 5). Subsequently, differential expression was calculated using Sleuth83. Finally, biological function and pathway analyses were performed using Cluster profiler78. RNA-seq raw data were deposited in the GEO database under the accession number GSE130651.

Insulin secretion and content

Transfected rat islet cells were pre-incubated for 30 min at 37 °C in Krebs–Ringer bicarbonate buffer (KRBH) containing 2 mM glucose, 25 mM HEPES, pH 7.4 and 0.1% BSA (Sigma-Aldrich), followed by 45 min incubation at 2 or 20 mM glucose. At the end of the incubation period, media were collected for insulin determination and rat islet cells were lysed with acid–ethanol (0.2 mM HCl in 75% ethanol) to extract total insulin content or with protein lysis buffer to measure total protein content (Bradford, BioRad). The amount of insulin released in the medium and remaining in the cells was measured by insulin Elisa kit (Mercodia). All experiments were performed in triplicates.

Cell death assay

TUNEL staining on rat β-cells was performed 48 h after transfection using the TMR red In Situ Cell Death Detection Kit (Roche) combined to polyclonal guinea pig anti-insulin (dilution 1:40, PA1-26938 Invitrogen) followed by incubation with goat anti-guinea-pig AlexaFluor 488 antibody (dilution 1:400, A11073 Thermofisher). Cell nuclei were stained with Hoechst 33342 (1 μg/ml, Invitrogen). Coverslips were mounted on microscope glass slides with Fluor-Save mounting medium (VWR International SA) and were visualized with a Zeiss Axiovision fluorescence microscope. A minimum of 103 cells were counted per condition. Incubation for 24 h with a mix pro-inflammatory cytokines (1 ng/mL IL-1β, 10 ng/mL TNF-α and 30 ng/mL IFN-γ) was used as positive control. Experiments were performed in single replicates.

Proliferation assay

The proliferative capacity of the beta-cells was assessed by BrdU incorporation. Transfected islet cells were cultured on poly-l-lysine coated glass coverslips for a total of 72 h and BrdU (Ab142567, Abcam) at 10 µM final concentration was added to the culture media for the last 48 h. Cells were fixed with ice cold methanol and permeabilized with 0.5% (wt/vol) saponin (Sigma-Aldrich) and DNA was denatured with 2 N HCl. The coverslips were first incubated with monoclonal mouse anti-BrdU (dilution 1:400, BD55627, BD Biosciences) and polyclonal guinea pig anti-insulin (dilution 1:40, PA1-26938, Invitrogen) antibodies followed by incubation with goat anti-mouse Alexa-Fluor-555 (dilution 1:400, A21422 Thermofisher) and goat anti-guinea-pig Alexa-Fluor-488 (dilution 1:400, A11073 Thermofisher) antibodies. At the end of the incubation, nuclei were stained with Hoechst 33342 (Invitrogen). Coverslips were mounted on microscope glass slides with Fluor-Save mounting medium (VWR International SA) and were visualized with a Zeiss Axiovision fluorescence microscope. Images of at least 103 cells per condition were collected. Incubation with Prolactin (PRL 500 ng/ml during 48 h) was used as positive control. Experiments were performed in single replicates.

Exocrine to β cell reprogramming

The experimental procedure of Acinar to β-cell reprogramming and for islet and β cell isolation was carried as described15,84. Briefly, primary exocrine cells were isolated from Mip-GFP mice85. Exocrine cells were cultured and infected by Ad-M3-mCherry (expressing PDX1, NGN3 MafA86). Day 3 and 6 cells were FACS-sorted to isolate mCherry and GFP fractions.

Adenovirus production, amplification and infections

The adenoviral plasmid coding for Ad-M3-mCherry was obtained from Addgene (Addgene #61041, Qiao Zhou). The mCherry adenoviral plasmid was a generous gift from Prof. Qiao Zhou (Harvard Stem Cell Institute). The DN-REST construct was a generous gift from Prof. Gail Mandel (Oregon Health and Science University) and adenoviral plasmid construction was performed using AdenoQuick2.0 system (O.D.260 Inc.). The human REST adenovirus87 was a generous gift from Dr. David Martin, Dr. Florent Allagnat and Prof. Jacques-Antoine Haefliger, Lausanne University Hospital. Adenoviral generation, amplification and infections were carried as previously described84. Exocrine cell infections were carried out immediately following cell isolation, in 6-well plates using exocrine-cell clusters containing 850 µg protein per well, in 2 mL of culture media containing the following virus titers: Ad-M3-mCherry-10*106 IFU/ml; Ad-hREST-10*106 IFU/ml; Ad-DN-REST-30*106 IFU/ml. 24 h following infection, cells were washed using culture media, and cells were plated on collagen-coated plates. MIN6 cells were infected with Ad-hREST or Ad-mCherry control at MOI 500. 24 h following infection, cells were washed using culture media and harvested for downstream analysis by qPCR 72 h post infection. Primer sequences for qPCR assays are provided in Table 3.

Data analysis of RNA-seq from reprogrammed β-like cells

To analyze Scrt1 and Rest expression in exocrine, β-, and β-like reprogrammed cells RNA-seq data from GEO (GSE128545) was used. Analysis was carried using UTAP (UTAP: User-friendly Transcriptome Analysis Pipeline88, Normalized counts of Scrt1 and REST were used to analyze their expression level in exocrine (Cherry−/GFP−), M3 infected (Cherry + /GFP−), reprogrammed β-like enriched (Cherry + /GFP +) and β cells (GFP + from islets of MIP-GFP mice).

ChIP-seq data analysis

To show transcription factor occupancy near the Scrt1 locus bigWig files were uploaded to IGV79 mm10 genome assembly: mouse NKX6-1 (GEO: GSE40975)38 (islets), mouse INSM1, FOXA2 and NeuroD1 (GEO: GSE54046)36(Jia et al., 2015) (islets), mouse H3K4Me3 (GEO: GSE63020)39 (islets), mouse REST (GEO: GSE27148)42 (mES cells), and human REST (GEO: GSE32465)89 (hES cells & PANC-1 cells) were downloaded from the Cistrome database90 ( Raw data (fastq sequence files) for mouse PDX1 binding in islets37 was obtained (Array Express, E-MTAB-1143) and analyzed by mapping against the mm10 with bowtie.

Statistical analysis

Data are expressed as mean ± SD. Statistical significance was determined using parametric unpaired two-tailed Student’s t-test or, for multiple comparisons, with one-way analysis of variance (ANOVA) of the means, followed by post-hoc Dunnett or Tukey test (Graph Pad Prism6). P-values less than 0.05 (p < 0.05) were considered statistically significant.

Schematic drawing

Schemes were created with the web application of

Data availability

ATAC-seq raw data were deposited in GEO under accession number GSE122747. Microarray data from30,45 are available in the GEO database under accession number GSE106919. RNA-seq raw data were deposited in the GEO database under accession number GSE130651.


  1. 1.

    Jacovetti, C., Matkovich, S. J., Rodriguez-Trejo, A., Guay, C. & Regazzi, R. Postnatal beta-cell maturation is associated with islet-specific microRNA changes induced by nutrient shifts at weaning. Nat. Commun. 6, 8084. (2015).

    ADS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Stolovich-Rain, M. et al. Weaning triggers a maturation step of pancreatic beta cells. Dev. Cell 32, 535–545. (2015).

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Aguayo-Mazzucato, C., Sanchez-Soto, C., Godinez-Puig, V., Gutierrez-Ospina, G. & Hiriart, M. Restructuring of pancreatic islets and insulin secretion in a postnatal critical window. PLoS ONE 1, e35. (2006).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Bliss, C. R. & Sharp, G. W. Glucose-induced insulin release in islets of young rats: Time-dependent potentiation and effects of 2-bromostearate. Am. J. Physiol. 263, E890-896. (1992).

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Bramswig, N. C. et al. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J. Clin. Investig. 123, 1275–1284 (2013).

  6. 6.

    Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627–632. (2008).

    ADS  CAS  Article  PubMed  Google Scholar 

  7. 7.

    Larque, C. et al. Transcriptome landmarks of the functional maturity of rat beta-cells, from lactation to adulthood. J. Mol. Endocrinol. 57, 45–59 (2016).

  8. 8.

    Fujitani, Y. Transcriptional regulation of pancreas development and &beta;-cell function [review]. Endocr. J. 64, 477–486 (2017).

    CAS  Article  Google Scholar 

  9. 9.

    Astro, V. & Adamo, A. Epigenetic control of endocrine pancreas differentiation in vitro: Current knowledge and future perspectives. Front. Cell Dev. Biol. 6, 141–141 (2018).

    Article  Google Scholar 

  10. 10.

    Avrahami, D. & Kaestner, K. H. Epigenetic regulation of pancreas development and function. Semin. Cell Dev. Biol. 23, 693–700 (2012).

    CAS  Article  Google Scholar 

  11. 11.

    Jermendy, A. et al. Rat neonatal beta cells lack the specialised metabolic phenotype of mature beta cells. Diabetologia 54, 594–604. (2011).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Ackermann, A. M., Wang, Z., Schug, J., Naji, A. & Kaestner, K. H. Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes. Mol. Metab. 5, 233–244 (2016).

    CAS  Article  Google Scholar 

  13. 13.

    Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213–1218 (2013).

    CAS  Article  Google Scholar 

  14. 14.

    Sobel, J. A. et al. Transcriptional regulatory logic of the diurnal cycle in the mouse liver. PLoS Biol. (2017).

  15. 15.

    Elhanani, O. et al. REST inhibits direct reprogramming of pancreatic exocrine to endocrine cells by preventing PDX1-mediated activation of endocrine genes. Cell Rep. 31, 107591. (2020).

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Blum, B. et al. Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3. Nat. Biotechnol. 30, 261–264. (2012).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137–R137 (2008).

    Article  Google Scholar 

  18. 18.

    Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).

  19. 19.

    Yu, G., Wang, L.-G. & He, Q.-Y. ChIPseeker: An R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382–2383 (2015).

    CAS  Article  Google Scholar 

  20. 20.

    Grant, C. E., Bailey, T. L. & Noble, W. S. FIMO: Scanning for occurrences of a given motif. Bioinformatics 27, 1017–1018 (2011).

    CAS  Article  Google Scholar 

  21. 21.

    Sandelin, A., Alkema, W., Engström, P., Wasserman, W. W. & Lenhard, B. JASPAR: An open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91–D94 (2004).

  22. 22.

    Sergushichev, A. An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. BioRxiv 060012–060012 (2016).

  23. 23.

    Qiu, W. L. et al. Deciphering pancreatic islet beta cell and alpha cell maturation pathways and characteristic features at the single-cell level. Cell Metab. 27, 702. (2018).

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Zhu, Y., Liu, Q., Zhou, Z. & Ikeda, Y. PDX1, Neurogenin-3, and MAFA: Critical transcription regulators for beta cell development and regeneration. Stem Cell Res. Ther. 8, 240. (2017).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Bastidas-Ponce, A. et al. Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic beta-cells. Mol. Metab. 6, 524–534. (2017).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Ray, J. D. et al. Nkx6.1-mediated insulin secretion and beta-cell proliferation is dependent on upregulation of c-Fos. FEBS Lett. 590, 1791–1803, (2016).

  27. 27.

    Alvarez-Dominguez, J. R. et al. Circadian entrainment triggers maturation of human in vitro islets. Cell Stem Cell 26, 108–122 e110, (2020).

  28. 28.

    Fajas, L. et al. Impaired pancreatic growth, beta cell mass, and beta cell function in E2F1 (−/− )mice. J. Clin. Invest. 113, 1288–1295. (2004).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1–22 (2010).

    Article  Google Scholar 

  30. 30.

    Jacovetti, C., Matkovich, S. J., Rodriguez-Trejo, A., Guay, C. & Regazzi, R. Postnatal β-cell maturation is associated with islet-specific microRNA changes induced by nutrient shifts at weaning. Nat. Commun. 6 (2015).

  31. 31.

    Pasquali, L. et al. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat. Genet. 46, 136–143 (2014).

    CAS  Article  Google Scholar 

  32. 32.

    Artner, I. et al. MafA and MafB regulate genes critical to beta-cells in a unique temporal manner. Diabetes 59, 2530–2539. (2010).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Marı́n, F. & Nieto, M. A. The expression of Scratch genes in the developing and adult brain. Dev. Dyn. 235, 2586–2591 (2006).

  34. 34.

    Itoh, Y. et al. Scratch regulates neuronal migration onset via an epithelial-mesenchymal transition-like mechanism. Nat. Neurosci. 16, 416–416 (2013).

    CAS  Article  Google Scholar 

  35. 35.

    Matsuda, T. et al. Pioneer factor NeuroD1 rearranges transcriptional and epigenetic profiles to execute microglia-neuron conversion. Neuron 101, 472–485 (2019).

  36. 36.

    Jia, S. et al. Insm1 cooperates with Neurod1 and Foxa2 to maintain mature pancreatic beta-cell function. EMBO J. 34, 1417–1433. (2015).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Khoo, C. et al. Research resource: The pdx1 cistrome of pancreatic islets. Mol. Endocrinol. 26, 521–533. (2012).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Taylor, B. L., Liu, F. F. & Sander, M. Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells. Cell Rep. 4, 1262–1275, (2013).

  39. 39.

    Lin, W. et al. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation. Mol. Cancer Res. 13, 689–698. (2015).

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Martin, D. et al. Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cells. Diabetologia 51, 1429–1439. (2008).

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Martin, D. et al. Specific silencing of the REST target genes in insulin-secreting cells uncovers their participation in beta cell survival. PLoS ONE 7, e45844. (2012).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Arnold, P. et al. Modeling of epigenome dynamics identifies transcription factors that mediate Polycomb targeting. Genome Res. 23, 60–73. (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Chong, J. A. et al. REST: A mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80, 949–957. (1995).

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Stolovich-Rain, M. et al. Weaning triggers a maturation step of pancreatic β cells. Dev. Cell 32, 535–545 (2015).

    CAS  Article  Google Scholar 

  45. 45.

    Sanchez-Parra, C. et al. Contribution of the long noncoding RNA H19 to β-cell mass expansion in neonatal and adult rodents. Diabetes 67, 2254–2267 (2018).

  46. 46.

    Gaulton, K. J. et al. A map of open chromatin in human pancreatic islets. Nat. Genet. 42, 255–255 (2010).

    CAS  Article  Google Scholar 

  47. 47.

    Varshney, A. et al. Genetic regulatory signatures underlying islet gene expression and type 2 diabetes. Proc. Natl. Acad. Sci. 114, 2301–2306 (2017).

  48. 48.

    Thurner, M. et al. Integration of human pancreatic islet genomic data refines regulatory mechanisms at type 2 diabetes susceptibility loci. Elife 7, e31977–e31977 (2018).

    Article  Google Scholar 

  49. 49.

    Greenwald, W. W. et al. Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk. Nat. Commun. 10, 2078–2078 (2019).

    ADS  Article  Google Scholar 

  50. 50.

    Bysani, M. et al. ATAC-seq reveals alterations in open chromatin in pancreatic islets from subjects with type 2 diabetes. Sci. Rep. 9, 7785–7785 (2019).

    ADS  Article  Google Scholar 

  51. 51.

    Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC-seq: A method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21–29 (2015).

  52. 52.

    Piskacek, M., Zotova, L., Zsurka, G. & Schweyen, R. J. Conditional knockdown of hMRS2 results in loss of mitochondrial Mg+ uptake and cell death. J. Cell. Mol. Med. 13, 693–700 (2009).

  53. 53.

    Chan, K. H. K. et al. Genetic variations in magnesium-related ion channels may affect diabetes risk among African American and Hispanic American women. J. Nutr. 145, 418–424 (2015).

  54. 54.

    Schmitz, C., Deason, F. & Perraud, A.-L. Molecular components of vertebrate Mg 2+-homeostasis regulation. Magnes. Res. 20, 6–18 (2007).

  55. 55.

    Conrad, E., Stein, R. & Hunter, C. S. Revealing transcription factors during human pancreatic β cell development. Trends Endocrinol. Metab. 25, 407–414 (2014).

  56. 56.

    Jacovetti, C. et al. MicroRNAs modulate core-clock gene expression in pancreatic islets during early postnatal life in rats. Diabetologia 60, 2011–2020 (2017).

  57. 57.

    Aguayo-Mazzucato, C. et al. Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells. Diabetologia 54, 583–593. (2011).

    CAS  Article  PubMed  Google Scholar 

  58. 58.

    Huang, C. et al. Synaptotagmin 4 regulates pancreatic beta cell maturation by modulating the Ca(2+) sensitivity of insulin secretion vesicles. Dev. Cell 45, 347–361 e345, (2018).

  59. 59.

    Chriett, S. et al. SCRT1 is a novel beta cell transcription factor with insulin regulatory properties. Mol. Cell Endocrinol. 521, 111107 (2021).

    CAS  Article  Google Scholar 

  60. 60.

    Arda, H. E. et al. Age-dependent pancreatic gene regulation reveals mechanisms governing human beta cell function. Cell Metab. 23, 909–920. (2016).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  61. 61.

    Heit, J. J. et al. Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function. Nature 443, 345–345 (2006).

    ADS  CAS  Article  Google Scholar 

  62. 62.

    Goodyer, W. R. et al. Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT. Dev. Cell 23, 21–34 (2012).

  63. 63.

    Cheng, K. et al. Hypoxia-inducible factor-1α regulates β cell function in mouse and human islets. J. Clin. Investig. 120, 2171–2183 (2010).

  64. 64.

    Masini, M. et al. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 52, 1083–1086 (2009).

  65. 65.

    Márquez-Aguirre, A. L., Canales-Aguirre, A. A., Padilla-Camberos, E., Esquivel-Solis, H. & Dı́az-Martı́nez, N. E. Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy. Braz. J. Med. Biol. Res. 48, 765–776 (2015).

  66. 66.

    Farack, L. et al. Transcriptional heterogeneity of beta cells in the intact pancreas. Dev. Cell 48, 115–125 (2019).

  67. 67.

    Krentz, N. A. J. et al. Single-cell transcriptome profiling of mouse and hESC-derived pancreatic progenitors. Stem Cell Rep. 11, 1551–1564 (2018).

  68. 68.

    Zeng, C. et al. Pseudotemporal ordering of single cells reveals metabolic control of postnatal β cell proliferation. Cell Metab. 25, 1160–1175 (2017).

  69. 69.

    Gotoh, M. et al. Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation 43, 725–730 (1987).

  70. 70.

    Guay, C. et al. Lymphocyte-derived exosomal microRNAs promote pancreatic β cell death and may contribute to type 1 diabetes development. Cell Metab. 29, 348-361.e346 (2019).

    CAS  Article  Google Scholar 

  71. 71.

    Köhler, M. et al. One-step purification of functional human and rat pancreatic alpha cells. Integr. Biol. (Camb.) 4, 209–209 (2012).

    Article  Google Scholar 

  72. 72.

    Parnaud, G. et al. Proliferation of sorted human and rat beta cells. Diabetologia 51, 91–100 (2007).

    Article  Google Scholar 

  73. 73.

    Andrews, S. FastQC: A Quality Control Tool for High Throughput Sequence Data [Internet] (Babraham Bioinformatics, The Babraham Institute, 2010).

    Google Scholar 

  74. 74.

    Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).

  75. 75.

    Lassmann, T., Hayashizaki, Y. & Daub, C. O. SAMStat: Monitoring biases in next generation sequencing data. Bioinformatics 27, 130–131 (2010).

  76. 76.

    Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).

  77. 77.

    Piper, J. et al. Wellington: A novel method for the accurate identification of digital genomic footprints from DNase-seq data. Nucleic Acids Res. 41, e201–e201 (2013).

    CAS  Article  Google Scholar 

  78. 78.

    Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: An R package for comparing biological themes among gene clusters. Omics 16, 284–287 (2012).

  79. 79.

    Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011).

  80. 80.

    Fresno, C. & Fernandez, E. A. RDAVIDWebService: A versatile R interface to DAVID. Bioinformatics 29, 2810–2811 (2013).

    CAS  Article  Google Scholar 

  81. 81.

    Hohmeier, H. E. et al. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and-independent glucose-stimulated insulin secretion. Diabetes 49, 424–430 (2000).

  82. 82.

    Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525–525 (2016).

    CAS  Article  Google Scholar 

  83. 83.

    Pimentel, H., Bray, N. L., Puente, S., Melsted, P. & Pachter, L. Differential analysis of RNA-seq incorporating quantification uncertainty. Nat. Methods 14, 687–687 (2017).

    CAS  Article  Google Scholar 

  84. 84.

    Elhanani O., W. M. Protocol for studying reprogramming of mouse pancreatic acinar cells to β-like cells. STAR Protoc. 1, (2020).

  85. 85.

    Hara, M. et al. Transgenic mice with green fluorescent protein-labeled pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 284, E177-183. (2003).

    CAS  Article  PubMed  Google Scholar 

  86. 86.

    Li, W. et al. In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes. Elife 3, e01846. (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  87. 87.

    Martin, D. et al. Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines. J. Biol. Chem. 278, 53082–53089. (2003).

    CAS  Article  PubMed  Google Scholar 

  88. 88.

    Kohen, R. et al. UTAP: User-friendly transcriptome analysis pipeline. BMC Bioinform. 20, 154. (2019).

    Article  Google Scholar 

  89. 89.

    Gertz, J. et al. Distinct properties of cell-type-specific and shared transcription factor binding sites. Mol. Cell 52, 25–36. (2013).

    CAS  Article  PubMed  Google Scholar 

  90. 90.

    Mei, S. et al. Cistrome data browser: A data portal for ChIP-Seq and chromatin accessibility data in human and mouse. Nucleic Acids Res. 45, D658–D662. (2017).

    CAS  Article  PubMed  Google Scholar 

Download references


We thank Charlotte Horr and Antonio Carlos Alves Meireles Filho for insightful discussions regarding the ATAC-seq sample preparation. This work was supported by the Swiss National Science Foundation (310030_169480 and 310030_188447 (R.R.)). We are grateful to the Placide Nicod Foundation for their financial support (J.S.). M.D.W is the incumbent of the Martin Meyer and Jenny Cyker Chair of Diabetes Research at the Weizmann Institute.

Author information




J.S., C.G., and R.R. designed research; C.G., O.E, V.M., A.R.T., C.J. and L.S. performed research; J.S., O.E. and C.G. analyzed data; J.S. and R.R. wrote the manuscript; J.S., C.G., O.E, M.D.W. and R.R. revised the manuscript. All authors approved the final version.

Corresponding author

Correspondence to Romano Regazzi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sobel, J., Guay, C., Elhanani, O. et al. Scrt1, a transcriptional regulator of β-cell proliferation identified by differential chromatin accessibility during islet maturation. Sci Rep 11, 8800 (2021).

Download citation


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing